4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-008344
Director sold 6,000 shares at an average $67.83 ($406,970)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CARTER BRUCE L A Director | 2022-03-21 | Option exercise | +6,000 | $25.58 | $153,480 | 6,000 | D: show line 1 in the form |
| CARTER BRUCE L A Director | 2022-03-21 | Sale | −2,676 | $66.70 | $178,489 | 3,324 | D: show line 2 in the form |
| CARTER BRUCE L A Director | 2022-03-21 | Sale | −307 | $67.23 | $20,640 | 3,017 | D: show line 3 in the form |
| CARTER BRUCE L A Director | 2022-03-21 | Sale | −2,210 | $68.66 | $151,739 | 807 | D: show line 4 in the form |
| CARTER BRUCE L A Director | 2022-03-21 | Sale | −807 | $69.52 | $56,103 | 0 | D: show line 5 in the form |
| Open-market sales · 6,000 sh · avg $67.83 · $406,970 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CARTER BRUCE L A Director | 2022-03-21 | Option exercise · Stock Option (Right to Buy) | −6,000 | 0 | D: show line 6 in the form |
Loading xslF345X03/form4.xml…